Document is current
Any future updates will be listed below
-
Authors
Nakashima, Naoki
Noda, Mitsuhiko
Ueki, Kohjiro
Koga, Tatsuhiko
Hayashi, Michio
Yamazaki, Katsuya
Nakagami, Tomoko
Ohara, Makoto
Gochi, Akira
Matsumura, Yasushi
Kimura, Michio
Ohe, Kazuhiko
Kang, Dongchon
Toya, Yoshiyuki
Yamagata, Kunihiro
Yokote, Koutaro
Ikeda, Shunya
Mitsutake, Naohiro
Yamamoto, Ryuichi
Tanizawa, Yukio
- License Information
-
More Information
Article History
First Online: 25 April 2019
Compliance with ethical standards
:
: Naoki Nakashima has received research grants from Fujitsu Ltd. Kohjiro Ueki has received honoraria for lectures from Astellas Pharma Inc., AstraZeneca Co., Ltd., Daiichi Sankyo Co. Ltd., Eli Lilly Japan Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Mitsubishi Tanabe Co. Ltd., MSD Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co. Ltd, Sanofi Aventis Co. Ltd, Shionogi & Co. Ltd., Sumitomo Dainippon Co. Ltd, Taisho Toyama Pharmaceutical Co. Ltd., and Takeda Pharmaceutical Co Ltd., and research grants from Astellas Pharma Inc. He has also received scholarship grants from Astellas Pharma Inc, Daiichi Sankyo Co. Ltd., Eli Lilly Japan Co. Ltd., Kowa Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Mitsubishi Tanabe Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co. Ltd., Sanofi Aventis Co. Ltd., Sumitomo Dainippon Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., and Takeda Pharmaceutical Co Ltd. Koutaro Yokote has received honoraria for lectures from Astellas Pharma Inc., Astellas Amgen BioPharma Co. Ltd., AstraZeneca Co., Ltd., MSD Co. Ltd., Ono Pharmaceutical Co. Ltd., Sanwa Kagaku Kenkyusho Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Kowa Co. Ltd., Kowa Pharmaceutical Co., Ltd, Sanofi Aventis Co. Ltd., Shionogi & Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co Ltd., Mitsubishi Tanabe Co. Ltd., Daiichi Sankyo Co. Ltd., Sumitomo Dainippon Co. Ltd., Eli Lilly Japan Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Pfizer Japan Inc., and Mochida Pharmaceutical Co. Ltd., and research grants from Astellas Pharma Inc. He has also received scholarship grants from Astellas Pharma Inc., MSD Co. Ltd., Ono Pharmaceutical Co. Ltd., Shionogi & Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Co. Ltd., Teijin Pharm Ltd., Daiichi Sankyo Co. Ltd., Sumitomo Dainippon Co. Ltd., Eli Lilly Japan Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novo Nordisk Pharma Ltd., Pfizer Japan Inc., and Mochida Pharmaceutical Co. Ltd., and a course endowed by MSD Co. Ltd. Mitsuhiko Noda, Tatsuhiko Koga, Michio Hayashi, Katsuya Yamazaki, Tomoko Nakagami, Makoto Ohara, Akira Gochi, Yasushi Matsumura, Michio Kimura, Kazuhiko Ohe, Dongchon Kang, Yoshiyuki Toya, Kunihiro Yamagata, Shunya Ikeda, Naohiro Mitsutake, Ryuichi Yamamoto, and Yukio Tanizawa have no conflict of interest.
: There are no ethical issues associated with this report.
